SIRP beta 1/gamma Antibody [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # AF2096W
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human SIRP beta 1
Gly26-Ala369 (Arg53His and Ala363Pro)
Accession # O00241
Gly26-Ala369 (Arg53His and Ala363Pro)
Accession # O00241
Specificity
Detects human SIRP beta 1 and human SIRP gamma in direct ELISAs and Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for SIRP beta 1/gamma Antibody [DyLight 650]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SIRP beta 1/gamma
Long Name
Signal-regulatory Protein beta 1/gamma
Alternate Names
CD172 antigen-like family member B, CD172b, signal-regulatory protein beta-1, SIRP-BETA-1
Gene Symbol
SIRPB1
Additional SIRP beta 1/gamma Products
Product Documents for SIRP beta 1/gamma Antibody [DyLight 650]
Product Specific Notices for SIRP beta 1/gamma Antibody [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...